Company Monitoring Page for Novartis

latest headlines for company on cafepharma

Novartis Shares Lower on Ex Dividend Trading, Reports of Kickbacks Fine In South Korea
TheStreet.com
Thu, 03/2/17 - 09:54 am
Tags:
Novartis, kickbacks, South Korea
Top 10 U.S. patent losses of 2017
Fierce Pharma
Thu, 02/23/17 - 09:29 am
Tags:
patents, Copaxone, Cialis, Viagra, Velcade, Sustiva, Sandostatin LAR, Norditropin, Viread, Pristiq, Strattera, Pfizer, Teva, Takeda, Eli Lilly, Novartis, Bristol-Myers Squibb, Novo Nordisk, Gilead Sciences
The FDA opens an inside track to let Novartis race ahead on Zykadia as Roche rivalry heats up
Endpoints
Thu, 02/23/17 - 09:23 am
Tags:
FDA, Novartis, Zykadia, ALK-positive non-small cell lung cancer, non-small cell lung cancer, Roche, Alecensa
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat
Fierce Pharma
Wed, 02/15/17 - 09:41 am
Tags:
Teva Pharmaceutical, Copaxone, MS, multiple sclerosis, generics, Tecfidera, Biogen, Gilenya, Novartis, Aubagio, Sanofi
Novartis Has Bright Future
Yahoo/GuruFocus
Thu, 02/2/17 - 09:14 am
Tags:
Novartis
Transcript of Pharma CEOs Meeting With Trump
Investors Hub
Wed, 02/1/17 - 09:45 am
Tags:
Donald Trump, Eli Lilly, Merck, Amgen, Celgene, JNJ, Novartis, drug pricing
Pharma goes to Washington, Trump talks pricing
BioPharma Dive
Wed, 02/1/17 - 09:41 am
Tags:
pharma industry, drug pricing, Donald Trump, Eli Lilly, Amgen, Merck, Novartis, Celgene, JNJ
Sanofi's meningococcal vax rivalry with Novartis ends in $61.5M class-action settlement
Fierce Pharma
Mon, 01/30/17 - 10:58 pm
Tags:
Sanofi, meningococcal disease, Novartis, vaccines, Menveo, Menactra
Novartis silently yanks a troubled biosimilar application; Chinese antibody developer draws $39M round
Endpoints
Sun, 01/29/17 - 11:53 am
Tags:
Novartis, biosimilars, Zioxtenzo, Europe, Amgen, Neulasta, China
Novartis Out To Prove Its Oncology Doubters Wrong
Seeking Alpha
Sat, 01/28/17 - 02:22 pm
Tags:
Novartis, oncology, CAR-T
Novartis launches $5 bln share buyback, mulls Alcon spin-off
Yahoo/Reuters
Wed, 01/25/17 - 10:03 am
Tags:
Novartis, Alcon, share repurchase
Novartis beats 4Q profit forecasts
Yahoo/AP
Wed, 01/25/17 - 10:00 am
Tags:
Novartis, earnings
Novartis says court battle will delay its Enbrel copy until 2018 at least
Yahoo/Reuters
Wed, 01/25/17 - 09:58 am
Tags:
Novartis, Enbrel, patents, Erelzi, Amgen, biosimilars, rheumatoid arthritis
Fighting a generic onslaught, Novartis adds CAR-T to its growing list of late-stage blockbusters
Endpoints
Wed, 01/25/17 - 09:55 am
Tags:
Novartis, generics, CAR-T
Novartis’s 4Q16 Estimates: Expectations from Alcon
Market Realist
Tue, 01/24/17 - 10:03 am
Tags:
Novartis, earnings, Alcon
Novartis’s 4Q16 Estimates: Innovative Medicines Segment
Market Realist
Mon, 01/23/17 - 10:20 am
Tags:
Novartis, earnings
Earnings preview: 7 biopharmas to watch
BioPharma Dive
Sat, 01/21/17 - 11:49 am
Tags:
earnings, JNJ, Novartis, Vertex Pharmaceuticals, Biogen, Celgene, Bristol-Myers Squibb, AbbVie
Novartis chief Jimenez touts two top PhIII drug prospects
Endpoints
Wed, 01/18/17 - 10:07 am
Tags:
Novartis, Joe Jimenez, CTL-019, BAF-312, CAR-T, progressive MS, multiple sclerosis
[video]Novartis CEO Discusses Impact of Trump on Drug Industry
Marketwatch
Wed, 01/18/17 - 09:58 am
Tags:
Novartis, Pharma CEOs, Donald Trump, Joe Jimenez
Novartis scouts new tech partnerships to build lead on 'risk averse' pharma peers
Fierce Pharma
Tue, 01/17/17 - 09:59 am
Tags:
Novartis, M&A

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.